Insider · CIK 0001617541
Katina Dorton
director
Files at Mallinckrodt plc, FULC (Fulcrum Therapeutics, Inc.), TCRX (TScan Therapeutics, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 14, 2025 | - Mallinckrodt plc | AGrant or award Restricted Stock Unitsderivative | +4,062 | $0.00 | $0 | 25,948 | Aug 18, 2025 |
| Jul 31, 2025 | - Mallinckrodt plc | AGrant or award Restricted Stock Unitsderivative | +16,414 | $0.00 | $0 | 21,886 | Aug 4, 2025 |
| Jun 30, 2025 | TCRX TScan Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +67,000 | $0.00 | $0 | 67,000 | Jul 2, 2025 |
| Jun 26, 2025 | FULC Fulcrum Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +36,000 | $0.00 | $0 | 36,000 | Jun 30, 2025 |
| Jan 1, 2025 | - Mallinckrodt plc | MOption exercise Ordinary Shares | +1,504 | - | - | 1,504 | Jan 2, 2025 |
| Jan 1, 2025 | - Mallinckrodt plc | FTax withholding Ordinary Shares | -294 | - | - | 1,210 | Jan 2, 2025 |
| Jan 1, 2025 | - Mallinckrodt plc | DDisposition to issuer Restricted Stock Unitsderivative | -1,231 | - | - | 6,976 | Jan 2, 2025 |
| Jan 1, 2025 | - Mallinckrodt plc | MOption exercise Restricted Stock Unitsderivative | -1,504 | $0.00 | $0 | 5,472 | Jan 2, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.